BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22531797)

  • 1. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.
    Bhaskaran K; Douglas I; Evans S; van Staa T; Smeeth L
    BMJ; 2012 Apr; 344():e2697. PubMed ID: 22531797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.
    Goh KL; Bhaskaran K; Minassian C; Evans SJ; Smeeth L; Douglas IJ
    Br J Clin Pharmacol; 2015 Feb; 79(2):337-50. PubMed ID: 25223602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
    Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
    BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of angiotensin receptor blockers and the risk of cancer.
    Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
    PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
    BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.
    Makar GA; Holmes JH; Yang YX
    J Natl Cancer Inst; 2014 Feb; 106(2):djt374. PubMed ID: 24431411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.
    Hicks BM; Filion KB; Yin H; Sakr L; Udell JA; Azoulay L
    BMJ; 2018 Oct; 363():k4209. PubMed ID: 30355745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
    Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
    Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
    BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
    Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
    Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis.
    Mukamal KJ; Ghimire S; Pandey R; Fiarman GS; Gautam S
    Ann Epidemiol; 2012 Oct; 22(10):747-50. PubMed ID: 22867943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered cancer risk with ACE inhibitors/ARBs: a population-based cohort study.
    Chiang YY; Chen KB; Tsai TH; Tsai WC
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):27-33. PubMed ID: 24304931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.
    Chen R; Suchard MA; Krumholz HM; Schuemie MJ; Shea S; Duke J; Pratt N; Reich CG; Madigan D; You SC; Ryan PB; Hripcsak G
    Hypertension; 2021 Sep; 78(3):591-603. PubMed ID: 34304580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
    J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.